WASHINGTON—U.S. Senators John Boozman (R-AR) and Cory Booker (D-NJ) introduced legislation to expand insurance coverage for prostate cancer screenings.
The bipartisan Prostate-Specific Antigen (PSA) Screening for High-risk Insured Men (HIM) Act would require private health insurance plans to cover preventive prostate cancer screenings without imposing any cost-sharing requirements for men who are at high risk of developing prostate cancer.
“Like so many others, my family has experienced the impact of this disease. Since we know early detection leads to better health outcomes, making access to screening easier can help save lives. I’m proud to work in a bipartisan way to expand prostate cancer detection and early intervention, particularly for at-risk men,” said Boozman.
FMT Image
“Prostate cancer is the second leading cause of cancer deaths in men in the United States, with Black men being disproportionately impacted and over twice as likely to die following a diagnosis,” said Booker. “I am proud to introduce this bipartisan legislation that will increase affordability and access to lifesaving screening services, help men detect the disease early, and save lives.”
Prostate cancer affects 1 in 8 American men in their lifetime and disproportionately affects African American men with 1 in 6 being diagnosed. Individuals who have at least one close family member diagnosed with the disease are at least twice as likely to be diagnosed themselves.
Currently, the Prostate-Specific Antigen test is the most effective tool for detection. When detected in early stage, it is almost 100 percent survivable.
“The PSA Screening for HIM Act is a crucial step toward removing financial barriers to life-saving prostate cancer screenings,” said American Urological Association Public Policy Council Chair Mark Edney, M.D. “By ensuring high-risk groups can access PSA testing without cost-sharing, this legislation will save countless lives through earlier detection, where survival rates are nearly 100 percent, compared to later stages where survival rates are around 30 percent.”
“The introduction of the PSA Screening for HIM Act represents a critical step forward in protecting men’s health and saving lives through early detection. At ZERO Prostate Cancer, we know that access to prostate cancer screening is fundamental in the fight against prostate cancer, particularly for those at highest risk,” said ZERO Prostate Cancer CEO Courtney Bugler.
“The PSA Screening for HIM Act would eliminate a significant hurdle that keeps far too many at high risk for prostate cancer from getting tested for the disease,” said Dr. Wayne A.I. Frederick, Interim Chief Executive Officer of the American Cancer Society and the American Cancer Society Cancer Action Network. “We thank Sens. Boozman and Booker for introducing this bill and look forward to working with them to get it passed.”
“With the increase in prostate cancer diagnoses and deaths, and the growing racial disparity, the PSA Screening for HIM Act is more important now than ever,” said Thomas A. Farrington, President and Founder of the Prostate Health Education Network (PHEN).
The full text of the bill can be found here.